|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Herein, we report that CD10, also known as common acute lymphoblastic leukemia antigen, neutral endopeptidase, or enkephalinase, can be used as a marker that, within heterogeneous populations of circulating CD66b<sup>+</sup> neutrophils present in inflammatory conditions, clearly distinguishes the mature from the immature ones.
|
28053192 |
2017 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
First identified in leukemia as a tumor-specific antigen (common acute lymphoblastic leukemia antigen), CD10 has become largely used in cancer diagnosis.
|
21425402 |
2011 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Neutral endopeptidase (NEP; EC 3.4.24.11) is a type-2 cell-surface metalloproteinase known by a variety of eponyms, including enkephalinase, common acute lymphoblastic leukemia antigen (CALLA), and CD10.
|
8602728 |
1996 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Most of the lymphoid blast crises of CML (73%) correspond to pure lymphoid transformation, all of them having a common acute lymphoblastic leukemia (ALL) phenotype (CD10+).
|
8396849 |
1993 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results illustrate that CD10, TdT double immunological marker analysis is a useful tool for early diagnosis of smoldering ALL in patients with a suspicious bone marrow, even when the bone marrow is hypoplastic.
|
8464231 |
1993 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
CD10 antigen density in childhood common acute lymphoblastic leukaemia: comparisons of race and sex.
|
1465029 |
1992 |
|
Common acute lymphoblastic leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
All five cases were classified as early pre-B; however, CD10 (common acute lymphoblastic leukemia antigen) was expressed at lower levels than other markers of B-cell lineage.
|
1534130 |
1992 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Northern blot analysis of RNAs from 63 leukemia samples showed that VpreB RNA was present in malignancies of precursor B cells, the expression being a feature of both common acute lymphoblastic leukemia (ALL) (CD10+) and null ALL (CD10-).
|
1884024 |
1991 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Two patients with common acute lymphoblastic leukemia antigen (CALLA) (CD10)-positive acute lymphoblastic leukemia and one patient with acute myelogenous leukemia, respectively, received high-dose chemoradiotherapy followed by marrow transplantation from either an HLA-identical sibling or HLA-mismatched parent.
|
2173884 |
1990 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Several established human glioma cell lines have been previously shown to express the common acute lymphoblastic leukemia antigen (cALLa, CD 10), an important marker in the diagnosis of human acute lymphocytic leukemia (ALL).
|
2531122 |
1989 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis.
|
2521388 |
1989 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The common acute lymphoblastic leukemia antigen (CALLA) is a 749-amino acid type II integral membrane protein that has been identified recently as the neutral endopeptidase 24.11 [NEP (EC 3.4.24.11)].
|
2528730 |
1989 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Immunologic study revealed that WSU-BL cells express IgM-lambda both in the cytoplasm and on the surface and react with monoclonal antibodies to B-cell antigens (B1, B4, BL3, BL4, HLA-DR, and common acute lymphoblastic leukemia antigen [CALLA]).
|
2527086 |
1989 |
|
Common acute lymphoblastic leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The cALL cells that are CD34 positive show increased expression of CD10 and are less likely to be CLA or Cmu positive, suggesting that they may represent a phenotypically less differentiated form of cALL than does CD34-negative cALL.
|
2957002 |
1987 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The reactivity of five anti-B monoclonal antibodies (McAb)-OKB2 (CD24), B4 (CD19), Leu12 (CD19), BA1 (CD24), B1 (CD20)--as well as the presence of cytoplasmic immunoglobulins (CyIg) were assessed in 100 cases of common acute lymphoblastic leukemia (cALL) at presentation (TdT+, J5 [CD10]+, HLA-Dr+).
|
3115807 |
1987 |
|
Common acute lymphoblastic leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Immunologic phenotyping suggested the leukemias were of B cell origin; blasts from five patients expressed HLA-DR and p24 (CD-9 antibody), blasts from three patients expressed B4 (CD-19), and blasts from two patients expressed the common acute lymphoblastic leukemia antigen (CD-10).
|
3947743 |
1986 |